569 related articles for article (PubMed ID: 11734921)
1. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
[TBL] [Abstract][Full Text] [Related]
2. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography.
Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
Nucl Med Commun; 2003 Jul; 24(7):755-62. PubMed ID: 12813193
[TBL] [Abstract][Full Text] [Related]
6. Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands.
Giordano A; Marozzi P; Meduri G; Ficola U; Calcagni ML; Vaccaro A; Rubini G; Attard M; Li Puma M; Ricci R; Corsello S
Eur J Nucl Med; 1999 Aug; 26(8):907-11. PubMed ID: 10436206
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma.
Mansi L; Rambaldi PF; Marino G; Pecori B; Del Vecchio E
Clin Nucl Med; 1996 Sep; 21(9):700-3. PubMed ID: 8879870
[TBL] [Abstract][Full Text] [Related]
9. Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands.
Yamaguchi S; Yachiku S; Hashimoto H; Kaneko S; Nishihara M; Niibori D; Shuke N; Aburano T
World J Surg; 2002 Jan; 26(1):29-34. PubMed ID: 11898030
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of technetium-99m-MIBI scan and intraoperative methylene blue staining for the localization of abnormal parathyroid glands.
Takei H; Iino Y; Endo K; Horiguchi J; Maemura M; Koibuchi Y; Horii Y; Yokoe T; Ishida T; Oyama T; Morishita Y
Surg Today; 1999; 29(4):307-12. PubMed ID: 10211559
[TBL] [Abstract][Full Text] [Related]
11. [Detection and localization of enlarged parathyroid glands in patients with hyperparathyroidism using 99mTc-methoxyisobutylisonitrile (MIBI): a study of subtraction scintigraphy with 99mTc-pertechnetate].
Katagiri M; Ohtawa T; Otsuka N; Morita K; Sone T; Mimura H; Yanagimoto S; Fukunaga M; Harada T
Kaku Igaku; 1995 May; 32(5):465-72. PubMed ID: 7596066
[TBL] [Abstract][Full Text] [Related]
12. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
13. Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions.
Mazzeo S; Caramella D; Lencioni R; Molea N; De Liperi A; Marcocci C; Miccoli P; Iacconi P; Bossio GB; Viacava P; Lazzeri E; Bartolozzi C
AJR Am J Roentgenol; 1996 Jun; 166(6):1465-70. PubMed ID: 8633466
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging (MRI) and technetium-99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism.
Wada A; Sugihara M; Sugimura K; Kuroda H
Radiat Med; 1999; 17(4):275-82. PubMed ID: 10510900
[TBL] [Abstract][Full Text] [Related]
15. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging.
Ishibashi M; Nishida H; Strauss HW; Kojima K; Fujito H; Watanabe J; Hiromatsu Y; Hayabuchi N
J Nucl Med; 1997 May; 38(5):706-11. PubMed ID: 9170432
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
[TBL] [Abstract][Full Text] [Related]
18.
Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
[TBL] [Abstract][Full Text] [Related]
19. Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy.
Kebapci M; Entok E; Kebapci N; Adapinar B
J Endocrinol Invest; 2004 Jan; 27(1):24-30. PubMed ID: 15053239
[TBL] [Abstract][Full Text] [Related]
20. The accuracy of 99m Tc-MIBI scintigraphy for preoperative parathyroid localization in primary and secondary-tertiary hyperparathyroidism.
Saengsuda Y
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S81-91. PubMed ID: 22619892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
